Haemonetics Acquires Cardiva Medical

Haemonetics Acquires Vivasure Medical

January 11, 2026

Medical Devices

Haemonetics Corporation has acquired Galway-based Vivasure Medical in a transaction valued at up to €185 million, consisting of an upfront €100 million payment plus up to €85 million in contingent milestone payments. The acquisition adds Vivasure's PerQseal Elite fully bioabsorbable vascular closure system to Haemonetics' large-bore closure portfolio; Vivasure has CE Mark approvals and has submitted a PMA to the U.S. FDA.

Haemonetics Corporation Acquires OpSens Inc.

December 12, 2023

Medical Devices

Haemonetics Corporation completed its acquisition of OpSens Inc. in an all-cash transaction for CAD $2.90 per share, representing a fully diluted equity value of approximately USD $255 million. The deal expands Haemonetics' hospital/interventional cardiology portfolio with OpSens' fiber-optic sensor technology (including the SavvyWire and OptoWire); OpSens will be delisted and Haemonetics expects OpSens to contribute $55–$65 million in revenue in fiscal 2025.

Haemonetics Acquires Attune Medical

March 5, 2024

Medical Devices

Haemonetics Corporation has agreed to acquire privately-held Attune Medical, the maker of the FDA-cleared ensoETM esophageal cooling device, for $160 million upfront plus contingent consideration. The acquisition will expand Haemonetics' electrophysiology and temperature-management capabilities and is expected to close in Haemonetics' fiscal 2025 first quarter.

Abbott Acquires Cardiovascular Systems, Inc.

February 8, 2023

Medical Devices

Abbott has agreed to acquire Cardiovascular Systems, Inc. (CSI) for $20.00 per share, representing an expected equity value of approximately $890 million. The acquisition adds CSI's orbital atherectomy system and early-stage vascular intervention pipeline to Abbott's vascular device portfolio to expand its capabilities in treating peripheral and coronary artery disease.

Cirtec Medical Acquires Cardea Catheter Innovations

July 26, 2021

Medical Devices

Cirtec Medical has acquired Cardea Catheter Innovations, a San Jose-based manufacturer of minimally invasive catheter devices and complex delivery systems. Cardea will integrate into Cirtec's NovelCath brand to expand the company's interventional capabilities across structural heart, electrophysiology, and neurovascular markets and will relocate into Cirtec's new San Jose Center of Excellence.

Hellman & Friedman Acquires Cordis from Cardinal Health

August 2, 2021

Medical Devices

Hellman & Friedman has completed the acquisition of Cardinal Health’s Cordis business for approximately $1 billion, with the buyer assuming certain liabilities and Cardinal Health retaining certain working capital accounts. Ajax Health and Zeus Health are partnering with H&F on the transaction; Cordis will operate as an independent medical device company headquartered in Miami Lakes, Florida.